Mary Lanning Healthcare (MLH) - Morrison Cancer Center (MCC) — Hastings, Nebraska

Mary Lanning Healthcare (MLH) - Morrison Cancer Center (MCC) is a clinical research site located in Hastings, Nebraska, United States 68901-4470.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Mary Lanning Healthcare (MLH) - Morrison Cancer Center (MCC) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Non-small Cell Lung Cancer.

Sponsors: BioNTech SE.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mary Lanning Healthcare (MLH) - Morrison Cancer Center (MCC)?

Mary Lanning Healthcare (MLH) - Morrison Cancer Center (MCC) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mary Lanning Healthcare (MLH) - Morrison Cancer Center (MCC) conducted?

Mary Lanning Healthcare (MLH) - Morrison Cancer Center (MCC) has 1 clinical trials on record, with 1 currently active. Their work covers Non-small Cell Lung Cancer.

Is Mary Lanning Healthcare (MLH) - Morrison Cancer Center (MCC) accredited by Crixeo Health?

Mary Lanning Healthcare (MLH) - Morrison Cancer Center (MCC) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mary Lanning Healthcare (MLH) - Morrison Cancer Center (MCC)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.